MétaCan
Menu
Back to cohort

Current State and New Horizons in Applications of Physiologically Based Biopharmaceutics Modeling (PBBM): A Workshop Report

2024· article· en· W4405438701 on OpenAlexafffundabout
Christer Tannergren, Sumit Arora, Andrew Babiskin, Luiza Borges, Parnali Chatterjee, Yi‐Hsien Cheng, André Dallmann, Anitha Govada, Tycho Heimbach, Martin Hingle, Sivacharan Kollipara, Evangelos Kotzagiorgis, Anders Lindahl, Claire Mackie, Maria Malamatari, Amitava Mitra, Rebecca Moody, Xavier Pépin, James E. Polli, Kimberly Raines, Gregory Rullo, Maitri Sanghavi, Rajesh S. Savkur, Rajendra Singh, Erik Sjögren, Sandra Suarez‐Sharp, Sherin Susan Thomas, Shereeni Veerasingham, Kevin Wei, Fang Wu, Yunming Xu, Miyoung Yoon, Bhagwant Rege

Bibliographic record

VenueMolecular Pharmaceutics · 2024
Typearticle
Languageen
FieldMedicine
TopicPharmaceutical studies and practices
Canadian institutionsHealth Canada
FundersNovartis PharmaU.S. Food and Drug AdministrationAgência Nacional de Vigilância SanitáriaUppsala UniversitetBayer HealthCareHealth CanadaAstraZenecaBayerTeva Pharmaceutical Industries
KeywordsBiopharmaceuticsNew horizonsState (computer science)PharmacologyChemistryMedicineEngineering ethicsComputer scienceEngineeringPharmacognosyBiochemistryProgramming language

Abstract

fetched live from OpenAlex

High Resolution Image Download MS PowerPoint Slide This report summarizes the proceedings for Day 3 of the workshop titled “ Physiologically Based Biopharmaceutics Modeling (PBBM) Best Practices for Drug Product Quality: Regulatory and Industry Perspectives ”. This day focused on the current and future drug product quality applications of PBBM from the innovator and generic industries as well as the regulatory agencies perspectives. The presentations, which included several case studies, covered the applications of PBBM in generic drug product development, applications of virtual bioequivalence trials to support formulation bridging and the utility of absorption modeling in clinical pharmacology assessments. In addition, recent progress in the prediction of colon absorption and in vivo performance of extended-release drug products was shared. The morning session was concluded by representatives from FDA, ANVISA, MHRA, Health Canada, EMA, and PMDA giving their perspectives on the application of PBBM in regulatory submissions. The afternoon breakout sessions focused on four parallel topics: 1) PBBM in generic drug product development; 2) virtual bioequivalence trials applications; 3) safe space and extrapolation; and 4) regional absorption and modified release PBBM applications. This allowed the participants to engage in in-depth discussions of best practices as well to identify key points of consideration to allow further progress on the applications of PBBM.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.028
metaresearch head score (Gemma)0.010
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: none
GenreCandidate signal: Review · Consensus signal: Review
Teacher disagreement score0.028
Threshold uncertainty score0.149

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0280.010
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0010.001
Science and technology studies0.0010.001
Scholarly communication0.0080.007
Open science0.0030.005
Research integrity0.0040.006
Insufficient payload (model declined to judge)0.0150.007

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.125
GPT teacher head0.443
Teacher spread0.318 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreReview

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations25
Published2024
Admission routes3
Has abstractyes

Explore more

Same venueMolecular PharmaceuticsSame topicPharmaceutical studies and practicesFrench-language works237,207